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General methods. 1,3-Dibutyl-5,6-diaminobenzimidazolium iodide1 and N, N’-
dibutylbenzimidazol-2-ylidene)gold(I) chloride (7)2 were prepared according to literature 
methods. All other reagents were used as received from commercial suppliers. NMR 
spectra were recorded on a Varian Innova 300 MHz or 500 MHz, using DMSO-d6, 
CD2Cl2 and CDCl3 as solvents. J values are given in Hz. Electrospray mass spectra (ESI-
MS) were recorded on a Micromass Quatro LC instrument; nitrogen was employed as 
drying and nebulizing gas. Elemental analyses were carried out on a TruSpec Micro 
Series.  
1. Synthesis and characterization of the compounds 
1.1. Synthesis of compound [1](I)3. Hexaketocyclohexane octahydrate (80 mg, 0.275 
mmol, 1 equiv.) and 1,3-dibutyl-5,6-diaminobenzimidazolium iodide (300 mg, 0.772 
mmol, 3 equiv.) were placed together in an oven-dried Schlenk flask and suspended in 
glacial acetic acid (15 mL) under inert atmosphere and heated at 140° C for 24 h. The 
mixture was filtered and the solid was subsequently washed with glacial acetic acid (5 
mL), and ethanol (50 mL) until the filtrate was colorless. Compound [1](I)3 (284.9 mg, 
81%) was isolated as a brown solid after filtration. H NMR (500 MHz, DMSO-d6) 10.33 
(s, 1H, NCHN), 9.32 (s, 2H, CHAr), 4.85-4.67 (m, 4H, NCH2CH2CH2CH3), 2.18-1.99 (m, 
4H, NCH2CH2CH2CH3), 1.60-1.43 (m, 4H, NCH2CH2CH2CH3), 1.04 (t, 
3JH-H = 10 Hz, 
6H, NCH2CH2CH2CH3). C NMR (126 MHz, DMSO-d6) 149.23 (NCHN), 145.16 (Cq 
Ar), 139.26 (Cq Ar), 134.42 (Cq Ar), 113.38 (CHAr), 47.21 (NCH2CH2CH2CH3), 30.45 
(NCH2CH2CH2CH3), 19.26 (NCH2CH2CH2CH3), 13.49 (NCH2CH2CH2CH3). 
Electrospray MS (20 V, m/z): 281 (M3+, 100%). Found: C, 48.3; H, 5.2; N, 13.6. 
C51H63N12I3·2H2O requires C, 48.6; H, 5.35; N, 13.3. 
1.2. Synthesis of compound [1](BF4)3. Under aerobic conditions, a suspension of [1](I)3 
(100 mg, 0.082 mmol) in dry CH2Cl2 (20 mL) was treated with [Et3O](BF4) (38.1 mg, 
0.245 mmol). The mixture was stirred at room temperature for 1 h. The solution was 
concentrated and diethyl ether (5 mL) was added for precipitation. The product was 
filtrated and washed with diethyl ether (5 mL). Compound [1](BF4)3 (78.4 mg, 87%) was 
isolated as a green solid. H NMR (500 MHz, DMSO-d6) 10.31 (s, 1H, NCHN), 9.32 (s, 
2H, CHAr), 4.96-4.63 (m, 4H, NCH2CH2CH2CH3), 2.25-1.96 (m, 4H, 
NCH2CH2CH2CH3), 1.67-1.42 (m, 4H, NCH2CH2CH2CH3), 1.16-0.89 (m, 6H, 
NCH2CH2CH2CH3). F NMR (282 MHz, DMSO-d6) -148.40. C NMR (126 MHz, 
DMSO-d6) 149.25 (NCHN), 145.18 (Cq Ar), 139.27 (Cq Ar), 134.44 (Cq Ar), 113.38 (CHAr), 
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47.17 (NCH2CH2CH2CH3), 30.46 (NCH2CH2CH2CH3), 19.25 (NCH2CH2CH2CH3), 
13.47 (NCH2CH2CH2CH3). Electrospray MS (20 V, m/z): 281 (M
3+, 100%). Found: C, 
52.8; H, 6.1; N, 14.6. C51H63N12B3F12·3H2O requires C, 52.8; H, 6.0; N, 14.5.  
1.3. Synthesis of compound [1][RuCl2I(p-cymene)]3. A suspension of compound 1(I)3 
(50 mg, 0.041 mmol) and [RuCl(p-cymene)]2 (37.5 mg, 0.061 mmol) in dry CH2Cl2 (20 
mL) was stirred at room temperature overnight. Then the volatiles were removed nearly 
to dryness and n-hexane (5 mL) was added.  The product was collected by filtration and 
washed with n-hexane (5 mL). Compound [1][RuCl2I(p-cymene)]3 (52.2 mg, 60%) was 
isolated as a red solid. H NMR (300 MHz, CDCl3) 10.85 (br s, 1H, NCHN), 8.95 (br s, 
2H, CHAr), 5.54 (br s, 2H, CHp-cym), 5.31 (br s, 2H, CHp-cym), 5.08-4.76 (m, 4H, 
NCH2CH2CH2CH3), 3.32-3.09 (m, 1H, CHisop p-cym), 2.32 (br s, 3H, CH3 p-cym), 2.22-1.97 
(m, 4H, NCH2CH2CH2CH3), 1.69-1.47 (m, 4H, NCH2CH2CH2CH3), 1.37 (d, 
3JH,H = 5 
Hz, 6H, CH3 isop p-cym), 1.04 (t, 
3JH-H = 6 Hz, 6H, NCH2CH2CH2CH3). C NMR (75 MHz, 
CDCl3) 151.41 (NCHN), 144.11 (Cq Ar), 140.36 (Cq Ar), 135.25 (Cq Ar), 113.64 (CHAr), 
96.71 (Cq p-cym), 81.85 (CH p-cym), 79.92 (CH p-cym), 48.50 (NCH2CH2CH2CH3), 31.39 
(NCH2CH2CH2CH3), 30.05 (CHisop p-cym), 22.48 (CH3 isop p-cym), 20.16 
(NCH2CH2CH2CH3), 19.07 (CH3 p-cym), 13.84 (NCH2CH2CH2CH3). Electrospray MS (20 
V, m/z): 281 (M3+, 100%) and 312 ([RuCl(p-cymene)(NCMe)]+, 30%). Electrospray 
negative MS (20 V, m/z): 433 ([RuCl2(p-cymene)(I)]
-, 30%). Found: C, 45.5; H, 4.95; N, 
7.8. C81H105N12Cl6I3Ru3 requires C, 45.4; H, 4.9; N, 7.8.   
1.4. Synthesis of complex 2. NaOtBu (40.8 µL, 0.082 mmol) was added dropwise to 
suspension of compound [1](I)3 (100 mg, 0.082 mmol), NaH (6.5 mg, 0.269 mmol) and 
[IrCl(cod)]2 (82.2 mg, 0.122 mmol) in THF (20 mL) at -78ºC. The mixture was allowed 
to reach room temperature overnight. Then the volatiles were removed and the solid 
residue was suspended in CH2Cl2. The suspension was then filtered through a pad of 
Celite to remove insoluble solids. The solvent was removed under reduced pressure. The 
product was purified by column chromatography. Elution with a mixture CH2Cl2/n-
hexane afforded a band that contained complex 2. Complex 2 (45.7 mg, 27%) was isolated 
as a yellow solid. H NMR (300 MHz, CDCl3) 8.50 (s, 2H, CHAr), 5.14 (br s, 2H, CHcod), 
5.02-4.85 (m, 2H, NCH2CH2CH2CH3), 4.85-4.68 (m, 2H, NCH2CH2CH2CH3), 3.15 (br 
s, 2H, CHcod), 2.46-2.16 (m, 8H, CH2 cod), 1.78-1.44 (m, 8H; 4H, NCH2CH2CH2CH3, 4H, 
NCH2CH2CH2CH3), 1.16 (t, 
3JH-H = 6 Hz, 6H, NCH2CH2CH2CH3). C NMR (75 MHz, 
CDCl3) 205.60 (Ir-Ccarbene), 142.91 (Cq Ar), 139.87 (Cq Ar), 139.29 (Cq Ar), 107.72 (CHAr), 
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88.07 (CHcod), 56.98 (CHcod), 49.05 (NCH2CH2CH2CH3), 33.08 (NCH2CH2CH2CH3), 
30.71 (CH2 cod), 30.27 (CH2 cod), 20.76 (NCH2CH2CH2CH3), 13.97 (NCH2CH2CH2CH3). 
Electrospray MS (20 V, m/z): 2123 ([M+H]+, 20%). Found: C, 42.4; H, 4.55; N, 7.9. 
C75H96N12I3Ir3 requires C, 42.4; H, 4.6; N, 7.9.  
1.5. Synthesis of complex 3. CO gas was bubbled through a solution of complex 2 (70 
mg, 0.033 mmol) in CH2Cl2 (20 mL) for 1h at 0ºC. The solution was then concentrated 
nearly to dryness and n-hexane was added for precipitation. The crude solid was washed 
three times with n-hexane to remove the released 1,5-cylooctadiene. Complex 3 (56.1 mg, 
87 %) was collected by filtration. max/cm-1 2069 and 1992 (CO). H NMR (300 MHz, 
CDCl3) 8.75 (s, 2H, CHAr), 5.01-4.82 (m, 2H, NCH2CH2CH2CH3), 4.82-4.60 (m, 2H, 
NCH2CH2CH2CH3), 2.31-2.05 (m, 4H, NCH2CH2CH2CH3), 1.75-1.62 (m, 4H, 
NCH2CH2CH2CH3), 1.12 (t, 
3JH-H = 9 Hz, 6H, NCH2CH2CH2CH3). C NMR (75MHz, 
CDCl3): δ 194.27 (Ir-CO), 181.54 (Ir-CO), 167.71 (Ir-Ccarbene), 143.57 (Cq Ar), 139.92 (Cq 
Ar), 138.38 (Cq Ar), 110.10 (CHAr), 49.79 (NCH2CH2CH2CH3), 30.65 
(NCH2CH2CH2CH3), 20.50 (NCH2CH2CH2CH3), 13.94 (NCH2CH2CH2CH3). 
Electrospray MS (20 V, m/z): 1967 ([M+H]+, 20%). Found: C, 34.85; H, 3.05; N, 8.55. 
C57H60N12I3Ir3O6 requires C, 34.8; H, 3.1; N, 8.55.  
1.6. Synthesis of complex 4. NaOtBu (40.8 µL, 0.082 mmol) was added dropwise to a 
suspension of compound [1](I)3 (100 mg, 0.082 mmol), NaH (6.5 mg, 0.269 mmol) and 
AuCl(SMe)2 (72.1 mg, 0.245 mmol) in THF (20 mL) at -78ºC. The mixture was allowed 
to reach room temperature overnight. Then a spatula of charcoal was added and the 
mixture was stirred for further 15 minutes. The volatiles were removed and the solid 
residue was suspended in CH2Cl2. The suspension was filtered through a pad of Celite to 
remove insoluble solids. The solvent was evaporated under reduced pressure. The product 
was purified by column chromatography. Elution with a mixture CH2Cl2/n-hexane 
afforded a band that contained complex 4. Complex 4 (34.1 mg, 23%) was isolated as a 
yellow solid. H NMR (500 MHz, CD2Cl2) 8.71 (s, 2H, CHAr), 4.84-4.67 (m, 4H, 
NCH2CH2CH2CH3), 2.23-2.08 (m, 4H, NCH2CH2CH2CH3), 1.68-1.61 (m, 4H, 
NCH2CH2CH2CH3), 1.09 (t, 
3JH-H = 5 Hz, 6H, NCH2CH2CH2CH3). C NMR (126 MHz, 
CD2Cl2) 197.23 (Au-Ccarbene), 144.18 (Cq Ar), 140.76 (Cq Ar), 137.80 (Cq Ar), 111.35 
(CHAr), 49.90 (NCH2CH2CH2CH3), 32.25 (NCH2CH2CH2CH3), 20.82 
(NCH2CH2CH2CH3), 14.17 (NCH2CH2CH2CH3). Electrospray MS (20 V, m/z): 1813 
S4 
 
([M+H]+, 30%). Found: C, 33.35; H, 3.4; N, 9.2. C51H60N12I3Au3 requires C, 33.8; H, 3.3; 
N, 9.3. 
1.7. Synthesis of complex 5. NaOtBu (22.6 µL, 0.041 mmol) was added dropwise to a 
suspension of compound [1](I)3 (50 mg, 0.041 mmol), NaH (3.3 mg, 0.137 mmol) and 
[Au(CNC)Cl] (56.5 mg, 0.122 mmol) in THF (20 mL) at -78ºC. The mixture was allowed 
to reach room temperature overnight. Under air, a spatula of charcoal was added and the 
mixture was stirred for further 15 minutes. Then the volatiles were removed and the solid 
residue was suspended in CH2Cl2. The suspension was filtered through a pad of Celite to 
remove insoluble solids. The volatiles were removed nearly to dryness and diethyl ether 
(5 mL) was for precipitation. The solid so formed was filtrated and washed with diethyl 
ether (5 mL). Complex 5 (20.5 mg, 24%) was isolated as a brown solid. H NMR (500 
MHz, CD2Cl2) 9.16 (s, 2H, CHAr), 8.20 (t, 
3JH-H = 8 Hz, 1H, CHpyridyl), 7.83 (d, 
3JH-H = 8 
Hz, 2H, CHpyridyl), 7.79 (d, 
3JH-H = 8 Hz, 2H, CHphenyl), 7.48-7.30 (m, 4H, CHphenyl), 7.22-
7.10 (m, 2H, CHphenyl), 4.96-4.82 (m, 4H, NCH2CH2CH2CH3), 2.15-2.13 (m, 4H, 
NCH2CH2CH2CH3), 1.56-1.43 (m, 4H, NCH2CH2CH2CH3), 0.89 (t, 
3JH-H = 5 Hz, 6H, 
NCH2CH2CH2CH3). C NMR (126 MHz, CD2Cl2) 172.33 (Au-Ccarbene), 165.28 (Cq CNC), 
164.26 (Cq CNC), 149.94 (Cq CNC), 145.16 (Cq Ar), 140.77 (Cq Ar), 137.64 (Cq Ar), 136.40 
(CHpyridyl), 133.57 (CHphenyl), 129.06 (CHphenyl), 127.31 (CHphenyl), 118.94 (CHphenyl), 
113.24 (CHAr), 104.52 (CHpyridyl), 50.80 (NCH2CH2CH2CH3), 31.84 
(NCH2CH2CH2CH3), 20.67 (NCH2CH2CH2CH3), 13.77 (NCH2CH2CH2CH3). 
Electrospray MS (20 V, m/z): 707 (M3+, 100%). Found: C, 49.0; H, 3.75; N, 8.4. 
C102H93N15Au3I3 requires C, 49.0; H, 3.75; N, 8.4. 
1.8. Synthesis of compound 6. A suspension of compound [1](I)3 (100 mg, 0.082 mmol) 
and Ag2O (97.5 mg, 0.408 mmol) in CH2Cl2 (20 mL), was stirred at room temperature 
overnight under the exclusion of light. Then the mixture was filtered through a pad of 
Celite to remove insoluble salts. The solution was concentrated nearly to dryness and 
diethyl ether (5 mL) was added to precipitate the complex, which was collected by 
filtration and further washed with diethyl ether. Complex 6 (28.2 mg, 39%) was isolated 
as a red solid. max/cm-1 1735 (CO). H NMR (300 MHz, CDCl3) 8.11 (s, 2H, CHAr), 
4.14-4.01 (m, 2H, NCH2CH2CH2CH3), 2.04-1.82 (m, 2H, NCH2CH2CH2CH3), 1.59-1.44 
(m, 4H, NCH2CH2CH2CH3), 1.35-1.18 (m, 4H, NCH2CH2CH2CH3), 1.05 (t, 
3JH-H = 6 Hz, 
6H, NCH2CH2CH2CH3). C NMR (75 MHz, CDCl3) 154.98 (NCON), 141.33 (Cq Ar), 
141.06 (Cq Ar), 135.92 (Cq Ar), 104.72 (CHAr), 41.86 (NCH2CH2CH2CH3), 30.07 
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(NCH2CH2CH2CH3), 29.84 (NCH2CH2CH2CH3), 20.40 (NCH2CH2CH2CH3), 13.90 
(NCH2CH2CH2CH3). Electrospray MS (20 V, m/z): 889 ([M+H]
+, 20%). Found: C, 68.9; 
H, 6.9; N, 18.7. C51H63N12O3 requires C, 68.9; H, 6.8; N, 18.9. 
 
2. Catalytic experiments 
2.1. Hydroamination of alkynes 
Typical procedure for catalysis hydroamination of alkynes: complex 4 (0.0016 mmol) or 
7 (0.005 mmol) and AgBF4 (0.01 mmol) were dissolved in MeCN (1 mL) in a thick-
walled Schlenk tube fitted with a Teflon cap and stirred for 5 minutes. Then the 
corresponding arylamine (0.55 mmol), phenylacetylene (0.50 mmol) and anisole as 
internal standard (0.50 mmol) were subsequently added. The resulting mixture was stirred 
at 90 ºC for the appropriate time. The evolution of the reactions and yields were 
determined by GC analysis. 
2.2. Synthesis of -aminonitriles (three-component Strecker reaction) 
A capped vessel containing a stirrer was charged with the corresponding ketone (0.5 
mmol), aniline (0.55 mmol), TMSCN (1 mmol), anisole as internal standard (0.5 mmol), 
complex 4 (0.0066 mmol) or 7 (0.02 mmol), and 2 mL of dichloromethane. The resulting 
mixture was stirred for 24 h at room temperature. The evolution of the reactions, yields 





3. Spectroscopic data 
























































































4. X-Ray Crystallography 
X-Ray Diffraction studies for compound [1][RuCl2I(p-cymene)]3. Crystals suitable for 
X-Ray studies of complex [1][RuCl2I(p-cymene)]3 were obtained by slow diffusion of 
hexane into a concentrated solution of dichloromethane and methanol. Diffraction data 
was collected on an Agilent SuperNova diffractometer equipped with an Atlas CCD 
detector using Mo-K radiation (= 0.71073 Å). Single crystals were mounted on a 
MicroMount® polymer tip (MiteGen) in a random orientation. Absorption corrections 
based on the multi-scan method were applied. Using Olex2,2 the structure of the complex 
was solved using Charge Flipping3 in Superflip and refined with ShelXL4 refinement 
package using Least Squares minimisation. Key details of the crystals and structure 
refinement data are summarized in Supplementary Table S1. 
The structure model exhibits significant disorder in the lattice solvent region and in the 
cation environment. The occupancy of these disordered components was refined. One of 
the n-butyl groups exhibits disorder; bond distance restrains (ShelX DFIX and SADI) 
were applied. The crystal contains a mixture of [RuCl3(p-cymene)]
 and [RuCl2I(p-
cymene)] conterions, which were refined with a 40% and 60% occupancy, respectively.   
The lattice solvent region has been treated using PLATON/SQUEEZE5 procedure.  H-
atoms were introduced and refined on a riding model. Non-hydrogen atoms were refined 
anisotropically. A global, enhanced rigid bond restrain (ShelX RIGU) was applied. 
CCDC- 1528547 contains the supplementary crystallographic data for this paper. 
 
Supplementary Table S1. Summary of crystal data, data collection, and structure 
refinement details of [1][RuCl2I(p-cymene)]3 
 
Empirical formula C84.56H83.22Cl12.57I1.8N12O2.95Ru3 
Formula weight 2292.12 
Temperature/K 293 
Crystal system trigonal 











ρcalc g/cm3 1.300 
μ/mm-1 1.185 
F(000) 3418.0 
Crystal size/mm3 0.2212 x 0.1837 x 0.0356 
2Θ range for data collection/° 6.89 to 51.992 
Index ranges -21 ≤ h ≤ 19, -17 ≤ k ≤ 19, -39 ≤ l ≤ 34 
Reflections collected 15067 
Independent reflections 6958 [Rint = 0.0447, Rsigma = 0.0579] 
Data/restraints/parameters 6958/405/369 
Goodness-of-fit on F2 1.027 
Final R indexes [I>=2σ (I)] R1 = 0.0830, wR2 = 0.2163 
Final R indexes [all data] R1 = 0.0998, wR2 = 0.2426 
Largest diff. peak/hole / e Å-3 1.90/-0.87 
Flack parameter 0.043(18) 
 
Preliminary molecular structure of compound 6 
 
Figure S1. Molecular structure of compound 6.  Ellipsoids are at 50% probability. Hydrogen atoms and 
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